Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001192482-20-000456
Filing Date
2020-06-10
Accepted
2020-06-10 12:57:58
Documents
1
Effectiveness Date
2020-06-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11964
  Complete submission text file 0001192482-20-000456.txt   13262
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-368640 | Film No.: 20954254
SIC: 2834 Pharmaceutical Preparations